Clinical Trial Update: CATIE- Schizophrenia Trial [Phase 4]

View source ↗

Summary

CATIE, a Phase 4 schizophrenia trial sponsored by the National Institute of Mental Health, has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED